Latest News

Date Title Topic
30 Jun 2016 NICE Issues Technology Appraisal Guidance for Ceritinib Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 Jun 2016 World GI 2016 Press Release: Anti-PD-L1 Immunotherapy Shows Response in Microsatellite-Stable Metastatic Colorectal Cancer in Combination with MEK Inhibition Gastrointestinal cancers - Cancer Immunology and Immunotherapy
28 Jun 2016 EMA Recommends To Extend Indications for Pembrolizumab Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
27 Jun 2016 EMA Reviews Gadolinium Contrast Agents Used in MRI Scans Imaging
27 Jun 2016 Press Release: EMA ESMO Workshop - Optimising the use of single arm trials in cancer drug development Anticancer agents & Biologic therapy
27 Jun 2016 ESMO Press Release: ESMO Launches First Leaders Generation Programme to Develop Oncology's Leaders of the Future
24 Jun 2016 EMA Recommends New Safety Measures for Idelalisib Palliative and supportive care - Haematologic malignancies - Anticancer agents & Biologic therapy
23 Jun 2016 ESMO Preceptorship on Breast Cancer – Portugal
23 Jun 2016 Epithelial-Mesenchymal Transition as a New Target Translational research - Anticancer agents & Biologic therapy
22 Jun 2016 June 2016 – Image of the Month
22 Jun 2016 EMA Recommends a Change to the Terms of the Marketing Authorisation for Carfilzomib Haematologic malignancies - Anticancer agents & Biologic therapy
21 Jun 2016 EU Commission Conference Pushes Personalised Medicine Agenda Personalised medicine - Bioethics, legal and economic issues
20 Jun 2016 The Anomaly of Anamorelin Palliative and supportive care
20 Jun 2016 NICE UK Updates its Quality Standard in Breast Cancer Breast cancer
17 Jun 2016 Registration Open for ESMO Asia 2016